Stock Price Quote

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE333.60-2.15 (-0.64 %)
PREV CLOSE ( ) 335.75
OPEN PRICE ( ) 333.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5126
TODAY'S LOW / HIGH ( )328.90 337.35
52 WK LOW / HIGH ( )245.05 511
NSE333.40-0.75 (-0.22 %)
PREV CLOSE( ) 334.15
OPEN PRICE ( ) 335.85
BID PRICE (QTY) 333.40 (697)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 50926
TODAY'S LOW / HIGH( ) 329.05 336.75
52 WK LOW / HIGH ( )275.7 513.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1993
Management Info
Sajankumar Rameshwarlal Bajaj - Chairman Sajankumar Rameshwarlal Bajaj - Managing Director
Registered Office

Address 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West),
Thane Dist,
Maharashtra-401604

Phone 022 6617400 / 401

Email bajajhealth@bajajhealth.com / investors@bajajhealth.com

Website www.bajajhealth.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

09Feb Appointment of Company Secretary and
Appointment of Ms. Apurva Bandivadekar as Company Secretary and Complian..
26Dec Announcement under Regulation 30 (LOD
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 for Resi..
01Dec Disclosure Under Regulation 30 Of SEB
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, this is..
17Nov Bajaj Healthcare informs about disclos
Bajaj Healthcare has informed that the Exchange has received the disclos..
13Nov Bajaj Healthcare informs about earning
Bajaj Healthcare has informed that it enclosed Earning Updates for the Q..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-21.9600000000001430.25
Gross Profit 63.2499999999999 582.17
Operating Profit 203.331084.44
Net Sales 1085.736732.92

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2145.85 (4.89%)
M.Cap ( in Cr)1325.71
Neuland Laboratories (BSE)
peergroup  7118.95 (0.84%)
M.Cap ( in Cr)9133.53
Alembic Pharma (BSE)
peergroup  1047.25 (4.19%)
M.Cap ( in Cr)20585.07
Glaxosmithkline Phar (BSE)
peergroup  2295.10 (1.75%)
M.Cap ( in Cr)38880.38
Glenmark Pharma (BSE)
peergroup  893.90 (3.64%)
M.Cap ( in Cr)25224.80

Shareholding Pattern

PROMOTERS 67.73%
NON-INSTITUTION 31.06%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Bajaj Healthcare Ltd.

Bajaj Healthcare Ltd. was incorporated in the year 1993. Its today's share price is 333.6. Its current market capitalisation stands at Rs 920.68 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6732.92 Cr and Total Income of Rs.6748.9 Cr. The company's management includes Kejal Shah, Loukik Tipnis, Ram B Banarse, Hemant R Karnik, Pakshal A Jain, Dhananjay S Hatle, Namrata Sajankumar Bajaj, Anil Jain, Sajankumar Rameshwarlal Bajaj, Sajankumar Rameshwarlal Bajaj.

It is listed on the BSE with a BSE Code of 539872 , NSE with an NSE Symbol of BAJAJHCARE and ISIN of INE411U01027. It's Registered office is at 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West)Thane Dist-401604, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Chaturvedi & Agrawal, Paresh Rakesh & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.